NCT03817359View on ClinicalTrials.gov

Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

December 27, 2018

Study Completion Date

December 27, 2018

Conditions

AnestheticsRemifentanilPropofol

Interventions

COMBINATION_PRODUCT

Remifentanil-propofol mixture

Participants receive total intravenous anesthesia with remifentanil-propofol mixture by single TCI pump in intervention group. All TCI target concentration adjustments or extra bolus of propofol or remifentanil during operation were based on BIS and ANI monitor.

Trial Locations (1)

114

Tri-Service General hospital, Taipei

All Listed Sponsors

lead

Tri-Service General Hospital

OTHER

NCT03817359 - Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery | Biotech Hunter | Biotech Hunter